Prof Kolawole Wahab, MD, MBBS, MPH, MSc, FMCP, FANA, FAAN is an expert in Neurology at University of Ilorin Teaching Hospital (Nigeria). Kolawole Wahab has authored 201 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 400 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Kolawole Wahab, MD, MBBS, MPH, MSc, FMCP, FANA, FAAN University of Ilorin Teaching Hospital Nigeria
400 ScienceLeadR Reputation 400
Network Map

Neurology

Subspecialties: Cardiology - Public Health - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026

Source: PubMed

University of Ilorin Teaching Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 201

Citations

Citations: 4 607 1st author: 18 Last author: 10 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis.
PMID 42586098 — blood, stroke, blood pressure, secondary prevention, drug-related side effects and adverse reactions, therapeutics, nervous system, history
Lancet Neurol Top journal20260
Frailty, clinical outcomes, and treatment effects of a care bundle in acute intracerebral haemorrhage: a post-hoc analysis of the INTERACT3 trial.
PMID 42556370 — mortality, patient care bundles, income, therapeutics, frailty, prognosis
Lancet Healthy Longev20260
Clinical characteristics and outcomes of intracerebral haemorrhage in young vs older adults: insights from the INTERACT3 trial.
PMID 42378499 — mortality, stroke, therapeutics
Eur Stroke J20260
Exploring MAPT-containing H1 and H2 haplotypes in Parkinson's disease across diverse populations.
PMID 42342696 — genes, parkinson disease, haplotypes, neurodegenerative diseases
NPJ Parkinsons Dis20260
Pathology and Genetics in a Global Cohort of Parkinsonian Disorders.
PMID 42258190 — dementia, lewy bodies, supranuclear palsy, progressive, parkinson disease, genetics, brain, parkinsonian disorders, pathology, biomarkers, movement disorders, diagnosis, nervous system diseases, paralysis, movement
JAMA Neurol20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 3 2

By status:

Completed 3
Recruiting 1

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 2
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Stroke Minimization Through Additive Anti atherosclerotic Agents in Routine Treatment II Study (SMAART II)
NCT05963568 — simvastatin, stroke, hydrochlorothiazide, ramipril, aspirin, antihypertensive agents, capsules, atenolol, medication adherence, therapeutics, lipids, single-pill combination
Phase 3Recruiting2026

LeadR Networks

Main global connection map